Cartalax dosing & administration
Chondroprotective tripeptide bioregulator (Ala-Glu-Asp) that activates chondrogenic differentiation through SOX9/COL2A1/aggrecan upregulation, reverses senescence-associated secretory phenotype in aging chondrocytes, and provides geroprotective effects through SIRT-6 upregulation and p16/p21/p53 suppression
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team
Dosing
How much do I take?
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
Timing
Best time to take
Take Cartalax at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.
With food?
Cartalax can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.
If stacking
Cartalax should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting your dose
Increase if
- You've tolerated the current dose for the recommended period without significant side effects
- Therapeutic goals haven't been met at the current dose level
- Your healthcare provider recommends dose escalation based on your response
- Lab work or clinical assessments support a higher dose
Decrease if
- Side effects are bothersome or impacting daily life despite management strategies
- You experience any signs of an adverse reaction
- Lab results indicate the need for dose reduction
- Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- Therapeutic goals being met with minimal side effects
- Stable and consistent response to treatment
- Lab values or clinical markers trending in the right direction
- Good tolerance with manageable or absent side effects
Administration
How do I use it?
Reconstitution
What you need
Injection
Route
Cartalax is administered Oral (capsule)—no injection required
Best sites
Storage
Before reconstitution
Store Cartalax in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Cartalax should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation — discard the vial
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Oral (capsule)—rotate sites if applicable
Maintain a consistent schedule for optimal results with Cartalax. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is it safe?
Side effects
Commonly reported: Mild injection site reaction, Mild GI discomfort, Mild fatigue, Transient joint stiffness
Less common: Temporary increase in joint discomfort
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Cartalax
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Cartalax should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Flagged pairings
- High-dose NSAIDs chronically — may mask the gradual improvements from Cartalax and some evidence suggests chronic NSAID use can impair cartilage repair — Use with caution—discuss with your healthcare provider.
- Immunosuppressive medications without medical guidance — Cartalax has immunomodulatory effects through cytokine regulation — Use with caution—discuss with your healthcare provider.
- Corticosteroid joint injections immediately preceding Cartalax treatment — local immunosuppression may impair the peptide's bioregulatory effects — Use with caution—discuss with your healthcare provider.
Published research
What the studies show
Myakisheva SN, Linkova NS, Diatlova AS · 2023
Cartilage-building peptides like cartalax activate chondrocytes and boost collagen production, helping stem cells repair damaged joint cartilage and potentially treating osteoarthritis.
Myakisheva SN, Linkova NS, Kozhevnikova EO · 2023
Research (2023) on cartalax contributes important scientific knowledge about its biological and pharmacological properties.
Linkova N, Khavinson V, Diatlova A · 2023
Research (2023) on cartalax contributes important scientific knowledge about its biological and pharmacological properties.
Ashapkin V, Khavinson V, Shilovsky G · 2020
Research (2020) on cartalax contributes important scientific knowledge about its biological and pharmacological properties.
Khavinson VKh, Tarnovskaia SI, Lin'kova NS · 2014
Research (2014) on cartalax contributes important scientific knowledge about its biological and pharmacological properties.
Head to head
Cartalax compared
Want the full picture?
The complete Cartalax research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.